Study of Irinotecan Liposome Injection as Second-line Regimen in Patients With Small Cell Lung Cancer (SCLC)
Clinical trial NCT04727853 · COMPLETED
Trial details
- NCT number
- NCT04727853
- Sponsor
- CSPC Ouyi Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-01
- Primary completion
- 2022-04-26
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.